Patents Assigned to IMMUSOFT CORPORATION
  • Patent number: 11103582
    Abstract: Materials and methods for treating a patient to express a therapeutic agent comprising administering a Kupffer cell-suppressing substance in combination with a vehicle for introducing, into the patient, an exogenous nucleic acid comprising a sequence for expression of the agent.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: August 31, 2021
    Assignee: IMMUSOFT CORPORATION
    Inventors: R. Scott McIvor, Perry B. Hackett, Jason Bell, Myra Christine Urness-Rusten, Elena Aronovich, David W. Hunter
  • Publication number: 20130143267
    Abstract: The present disclosure provides compositions and methods for transducing B cells. In particular, the present disclosure provides for vectors and methods for transducing resting B cells and methods for differentiating same to express a transgene of interest.
    Type: Application
    Filed: January 7, 2011
    Publication date: June 6, 2013
    Applicant: IMMUSOFT CORPORATION
    Inventors: Matthew Rein Scholz, Eric J. Herbig